circRNA Regulates Dopaminergic Synapse, MAPK, and Long-term Depression Pathways in Huntington Disease
- 2 September 2021
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 58 (12) , 6222-6231
Abstract
Huntington disease (HD) is the most common neurogenetic disorder caused by expansion of the CAG repeat in the HTT gene; nevertheless, the molecular bases of the disease are not fully understood. Non-coding RNAs have demonstrated to be involved in the physiopathology of HD. However, the role of circRNAs has not been investigated. The aim of this study was to identify the circRNAs with differential expression in a murine cell line model of HD and to identify the biological pathways regulated by the differentially expressed circRNAs. CircRNA expression was analyzed through a microarray, which specifically detects circular species of RNA. The expression patterns between a murine cell line expressing mutant Huntingtin and cells expressing wild-type Huntingtin were compared. We predicted the miRNAs with binding sites for the differentially expressed circRNAs and the corresponding target genes for those miRNAs. Using the target genes, we performed a function enrichment analysis. We identified 23 circRNAs differentially expressed, 19 downregulated and four upregulated. Most of the downregulated circRNAs derive from the Rere gene. The dopaminergic synapse, MAPK, and long-term depression pathways were significantly enriched. The three identified pathways have been previously associated with the physiopathology of HD. The understanding of the circRNA-miRNA-mRNA network involved in the molecular mechanisms driving HD can lead us to identify novel biomarkers and potential therapeutic targets. To the best of our knowledge, this is the first study analyzing circRNAs in a model of Huntington disease.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (FOSISS-273213)
This publication has 37 references indexed in Scilit:
- Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington’s diseaseNeuroscience, 2013
- Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor functionNeuroscience, 2011
- Does reduced [123I]-FP-CIT binding in Huntington's disease suggest pre-synaptic dopaminergic involvement?Clinical Neurology and Neurosurgery, 2010
- The Centrality of RNACell, 2009
- Huntington's disease: the case for genetic modifiersGenome Medicine, 2009
- Dopaminergic and Glutamatergic Signaling Crosstalk in Huntington's Disease Neurodegeneration: The Role of p25/Cyclin-Dependent Kinase 5The Journal of Neuroscience, 2008
- Protein misfolding inside cells: The case of huntingtin and Huntington's diseaseIUBMB Life, 2008
- A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics, 2004
- Atrophin 2 recruits histone deacetylase and is required for the function of multiple signaling centers during mouse embryogenesisDevelopment, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003